Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2001 8
2002 1
2003 4
2004 5
2005 5
2006 2
2007 4
2008 8
2009 1
2010 6
2011 5
2012 2
2013 4
2014 6
2015 7
2016 8
2017 7
2018 7
2019 5
2020 7
2021 1
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 20980681

101 results

Results by year

Filters applied: . Clear all
Page 1
The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Vandercappellen J, Liekens S, Bronckaers A, Noppen S, Ronsse I, Dillen C, Belleri M, Mitola S, Proost P, Presta M, Struyf S, Van Damme J. Vandercappellen J, et al. Mol Cancer Res. 2010 Mar;8(3):322-34. doi: 10.1158/1541-7786.MCR-09-0176. Epub 2010 Mar 9. Mol Cancer Res. 2010. PMID: 20215425 Free article.
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4.
Lasagni L, Francalanci M, Annunziato F, Lazzeri E, Giannini S, Cosmi L, Sagrinati C, Mazzinghi B, Orlando C, Maggi E, Marra F, Romagnani S, Serio M, Romagnani P. Lasagni L, et al. J Exp Med. 2003 Jun 2;197(11):1537-49. doi: 10.1084/jem.20021897. J Exp Med. 2003. PMID: 12782716 Free PMC article.
Stimulation of angiostatic platelet factor-4 variant (CXCL4L1/PF-4var) versus inhibition of angiogenic granulocyte chemotactic protein-2 (CXCL6/GCP-2) in normal and tumoral mesenchymal cells.
Vandercappellen J, Noppen S, Verbeke H, Put W, Conings R, Gouwy M, Schutyser E, Proost P, Sciot R, Geboes K, Opdenakker G, Van Damme J, Struyf S. Vandercappellen J, et al. J Leukoc Biol. 2007 Dec;82(6):1519-30. doi: 10.1189/jlb.0407206. Epub 2007 Sep 7. J Leukoc Biol. 2007. PMID: 17827342
CXCR3 ligands in disease and therapy.
Van Raemdonck K, Van den Steen PE, Liekens S, Van Damme J, Struyf S. Van Raemdonck K, et al. Cytokine Growth Factor Rev. 2015 Jun;26(3):311-27. doi: 10.1016/j.cytogfr.2014.11.009. Epub 2014 Nov 22. Cytokine Growth Factor Rev. 2015. PMID: 25498524 Review.
101 results